Publication | Closed Access

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Phase 1BPancreatic CancerMetastatic Pancreatic AdenocarcinomaMedicineImmunologyImmune Checkpoint InhibitorCancer TreatmentImmunotherapyOncologyRadiation Oncology